Enspectra Receives Series A Funding; Moves Forward in Widening Market for Skin Cancer Detection Breakthrough

Enspectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology, recently closed a $7.5 million Series A round led by Tsingyuan Ventures, a technology-focused venture fund based in Los Altos, Calif.

Funding success will serve several needs

“Fundraising has been one of our major focuses as we seek to take the startup to the next level,” said Gabriel Sanchez,

Building a Successful Roadmap to Commercialization – Recent Fogarty Institute Workshop Offers Insight on Taking Devices to Market

One of the most strategically important topics for a startup is commercialization – the point when a company transitions from research focus to generating revenue, scaling the organization, and potentially driving toward an exit. As part of its educational series, the Fogarty Institute recently hosted an impressive panel who offered their thoughts on managing this important phase of a company’s lifecycle.

Mobile Makerspace Concept for Hospitalized, Chronically Ill Patients Is Officially On the Move

What started as a vision to use a mobile makerspace as a tool to inspire young, chronically ill patients to learn, create and innovate – and help make lengthy hospital stays more palatable – is now becoming a reality, thanks to the generous support of Sheri Sobrato Brisson, a long-time supporter of seriously and chronically ill children,

Healyx Changes Lives by Treating Chronic Wounds

Lower-cost, more-effective treatments are the hallmark of many Fogarty Institute companies, and that is the principle Healyx is living up to with its device that provides gold standard care for a chronic problem at a significant cost reduction.

Non-healing wounds are a critical global issue, with over eight million Medicare patients afflicted at an annual cost of $31.7 billion in the U.S.

Stanford Neurosurgeon and Entrepreneur Inspires Audience at 20th Annual Fogarty Lecture

This year’s annual Thomas J. Fogarty Lecture marked a milestone with the celebration of its 20thanniversary. The series, hosted by Stanford Biodesign and co-sponsored by the Fogarty Institute, started as a gathering to discuss and promote medical innovation with approximately 30 people in attendance. Since then, it has grown into a preeminent opportunity to learn from the most notable innovators in health technology.

START TYPING AND PRESS ENTER TO SEARCH